太龙药业：第三期员工持股计划所持有1084.61万股已全部出售完毕

Core Viewpoint - Tai Long Pharmaceutical (600222.SH) has completed the sale of all 10.8461 million shares held under its third employee stock ownership plan, which has now been terminated [1] Summary by Relevant Sections - Employee Stock Ownership Plan - The third employee stock ownership plan has been fully executed and automatically terminated as of the announcement date [1] - The total number of shares sold under this plan amounts to 10.8461 million [1] - Asset Management - All assets held under the employee stock ownership plan are now converted into monetary assets [1] - The company will proceed with the liquidation and distribution of the related assets from the third employee stock ownership plan [1]